Consumer Defensive
Live Price
Offline$0.07
+0.00% today
1Y Change
-36.36%
Window
Jun 23, 2025 β Jun 15, 2026
Coverage: 246 bars Β· Jun 23, 2025 β Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
PURE Bioscience, Inc. (PURE) is a Consumer Defensive stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.07 and down 36.4% across the available one-year price window (Jun 23, 2025 β Jun 15, 2026). Baseline metrics include revenue growth of +112075.2%, EPS growth of +28.4%, a dividend yield of 0.0%. What stands out right now is revenue +112075.2%, EPS +28.4%, free cash flow -79512.8% with operating margin -82.3% and ROIC 1548.4%. Valuation is more restrained than many high-expectation growth names at price/sales 3.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PURE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+112075.2% vs +1.7% peer median
Operating Margin
Below sector median
-82.3% vs +6.6% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating story is still moving forward
Revenue is running at +112075.2% and EPS at +28.4%, with operating margin around -82.3%.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PURE
β
Normalized return
SPY
β
S&P 500
Excess Return
β
Relative to SPY
PURE Max Drawdown
-63.64%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Uses the longest available daily history for PURE and SPY.

Company Overview
PURE Bioscience, Inc.
Other OTC
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVΓRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.